Format

Send to:

Choose Destination
See comment in PubMed Commons below
Antimicrob Agents Chemother. 2006 Nov;50(11):3959-62. Epub 2006 Sep 18.

In vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections.

Author information

  • 1R. M. Alden Research Laboratory, 2021 Santa Monica Blvd, #740 East, Santa Monica, CA 90404, USA. ejcgmd@aol.com

Abstract

Against 443 aerobic and anaerobic bacteria isolated from diabetic foot infections, ceftobiprole MICs (microg/ml) at which 90% of the isolates tested were inhibited were as follows: methicillin-resistant Staphylococcus aureus, 1; methicillin-susceptible S. aureus and Staphylococcus lugdunensis, 0.5; Anaerococcus prevotii, 0.125; Finegoldia magna, 0.5; Peptoniphilus asaccharolyticus, 1; Peptostreptococcus anaerobius, 4; Escherichia coli and Enterobacter species, 0.125; Klebsiella species, 2; and Pseudomonas aeruginosa, 8.

PMID:
16982780
[PubMed - indexed for MEDLINE]
PMCID:
PMC1635191
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk